Loading…
CIK 0002104501 • 4 13F filings • Feb 12, 2026 – Aug 7, 2026
Import this data to Google Sheets with:
=jivedata("remedium-capital-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 3 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| Apogee Therapeutics Inc | COM | $44K | 25.9%Prev: 17.2% | 583,591 SH | Decreased-3,100 SH |
| Crescent Biopharma Inc | COM | $4K | 2.5%Prev: 1.4% | 361,250 SH | Decreased |
| Galecto Inc | COM | $3K | 1.6% | 120,473 SH | New |
| Jade Biosciences Inc | COM | $24K | 14.3%Prev: 7.8% | 1,577,750 SH | Decreased |
| Oruka Therapeutics Inc | COM | $47K | 27.6%Prev: 33.0% | 1,552,414 SH | Decreased-13,247 SH |
| Spyre Therapeutics Inc | COM | $48K | 28.0%Prev: 28.8% | 1,456,231 SH | Decreased-7,938 SH |
| 13F-HR/A |
| 0002104501-26-000010 |
| $281.2M |
| View |